This session highlights the latest abstracts in Aortic Valve/TAVR submitted to STS 2021.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Jessica Forcillo and Gilbert Tang (Commercial Relationships: Abbott Vascular: Consultant Advisory/Board, Speaker Honoraria; Medtronic; Consultant Advisory/Board, Speaker Honoraria; W. L. Gore & Associates, Consultant Advisory/Board)

Presentations:

1. Structural Valve Degeneration of Trifecta Versus Magna Aortic Valve Bioprostheses - Jolian Dahl

2. Do Patients With Preoperative Atrial Fibrillation Benefit From SAVR With Concomitant Surgical Ablation Compared To TAVR Alone? - Zehang Chen

3. Five-Year Outcomes of the Commence Trial Investigating Aortic Valve Replacement with a Novel Tissue Bioprosthesis - Joseph Bavaria

Commercial Relationships: CytoSorbents: Research Grant; Edwards Lifesciences: Consultant/Advisory, Research Grant, Speaker/Honoraria; Medtronic: Research Grant, Speaker/Honoraria; St. Jude/Abbott: Consultant/Advisory Board, Research Grant, Speaker/Honoraria, DSMB Chairman; Terumo: Research Grant, Speaker/Honoraria; W.L. Gore: Consultant/Advisory Board, Research Grant, Speaker/Honoraria

4. Comparison of Outcomes Between Transcatheter Aortic Valve Replacement and Mini-thoracotomy Surgical Aortic Valve Replacement: A Propensity-Matched Analysis - Ryan Vela

4. Outcomes of Aortic Valve Replacement for Chronic Aortic Insufficiency: Analysis of the Society of Thoracic Surgeons Database - Christopher Ryan

5. Cardiac Operations Following Transcatheter Aortic Valve Replacement - James Yun